Refine
Year of publication
- 2024 (3)
- 2022 (9)
- 2021 (7)
- 2020 (8)
- 2019 (13)
- 2018 (18)
- 2017 (10)
- 2016 (17)
- 2015 (11)
- 2014 (10)
- 2013 (8)
- 2012 (15)
- 2011 (3)
- 2010 (6)
- 2009 (2)
- 2008 (7)
- 2007 (6)
- 2006 (5)
- 2005 (4)
- 2004 (6)
- 2003 (8)
- 2002 (4)
- 2001 (4)
- 2000 (8)
- 1999 (4)
- 1998 (3)
- 1997 (5)
- 1996 (2)
- 1995 (1)
- 1993 (3)
- 1992 (1)
- 1991 (2)
- 1990 (1)
- 1989 (2)
- 1988 (2)
- 1987 (2)
- 1985 (2)
Institute
Document Type
- Article (132)
- Conference Proceeding (62)
- Part of a Book (13)
- Book (4)
- Lecture (3)
- Other (3)
- Report (2)
- Doctoral Thesis (1)
- Patent (1)
- Review (1)
Keywords
- Finite-Elemente-Methode (16)
- Einspielen <Werkstoff> (13)
- shakedown analysis (9)
- FEM (6)
- Limit analysis (6)
- Shakedown analysis (6)
- limit analysis (6)
- Einspielanalyse (4)
- Shakedown (4)
- Technische Mechanik (4)
We present an electromechanically coupled computational model for the investigation of a thin cardiac tissue construct consisting of human-induced pluripotent stem cell-derived atrial, ventricular and sinoatrial cardiomyocytes. The mechanical and electrophysiological parts of the finite element model, as well as their coupling are explained in detail. The model is implemented in the open source finite element code Code_Aster and is employed for the simulation of a thin circular membrane deflected by a monolayer of autonomously beating, circular, thin cardiac tissue. Two cardio-active drugs, S-Bay K8644 and veratridine, are applied in experiments and simulations and are investigated with respect to their chronotropic effects on the tissue. These results demonstrate the potential of coupled micro- and macroscopic electromechanical models of cardiac tissue to be adapted to experimental results at the cellular level. Further model improvements are discussed taking into account experimentally measurable quantities that can easily be extracted from the obtained experimental results. The goal is to estimate the potential to adapt the presented model to sample specific cell cultures.
The discovery of human induced pluripotent stem cells reprogrammed from somatic cells [1] and their ability to differentiate into cardiomyocytes (hiPSC-CMs) has provided a robust platform for drug screening [2]. Drug screenings are essential in the development of new components, particularly for evaluating the potential of drugs to induce life-threatening pro-arrhythmias. Between 1988 and 2009, 14 drugs have been removed from the market for this reason [3]. The microelectrode array (MEA) technique is a robust tool for drug screening as it detects the field potentials (FPs) for the entire cell culture. Furthermore, the propagation of the field potential can be examined on an electrode basis. To analyze MEA measurements in detail, we have developed an open-source tool.
Human induced pluripotent stem cells (hiPSCs) have shown to be promising in disease studies and drug screenings [1]. Cardiomyocytes derived from hiPSCs have been extensively investigated using patch-clamping and optical methods to compare their electromechanical behaviour relative to fully matured adult cells. Mathematical models can be used for translating findings on hiPSCCMs to adult cells [2] or to better understand the mechanisms of various ion channels when a drug is applied [3,4]. Paci et al. (2013) [3] developed the first model of hiPSC-CMs, which they later refined based on new data [3]. The model is based on iCells® (Fujifilm Cellular Dynamics, Inc. (FCDI), Madison WI, USA) but major differences among several cell lines and even within a single cell line have been found and motivate an approach for creating sample-specific models. We have developed an optimisation algorithm that parameterises the conductances (in S/F=Siemens/Farad) of the latest Paci et al. model (2018) [5] using current-voltage data obtained in individual patch-clamp experiments derived from an automated patch clamp system (Patchliner, Nanion Technologies GmbH, Munich).